Siga Technologies (SIGA) Retained Earnings (2010 - 2025)
Siga Technologies (SIGA) reported Retained Earnings of -$43.1 million for Q4 2025, down 88.59% on a YoY basis from -$377.6 million in Q4 2024, and down 14.43% quarter-over-quarter from -$37.6 million in Q3 2025.
Siga Technologies (SIGA) Retained Earnings (2010 - 2025) Analysis & Trends
Siga Technologies has reported Retained Earnings for 16 years, with the latest figure at -$43.1 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 88.59% year-over-year to -$43.1 million; the trailing twelve-month figure through Dec 2025 stood at -$43.1 million (down 88.59% YoY), and the FY2025 full-year result was -$43.1 million, down 88.59% from the prior year.
- Retained Earnings for Q4 2025 stood at -$43.1 million, down from -$37.6 million in the prior quarter.
- The five-year high for Retained Earnings was -$22.8 million in Q4 2024, with the low at -$119.2 million in Q3 2021.
- Historically, Retained Earnings has averaged -$68.0 million across 5 years, with a median of -$66.2 million in 2022.
- The largest YoY upside for Retained Earnings was 67.62% in 2025 against a maximum downside of 88.59% in 2025.
- Siga Technologies' Retained Earnings stood at -$51.8 million in 2021, then dropped by 23.26% to -$63.8 million in 2022, then soared by 38.96% to -$38.9 million in 2023, then surged by 41.36% to -$22.8 million in 2024, then sank by 88.59% to -$43.1 million in 2025.
- The last three Retained Earnings figures came in at -$43.1 million (Q4 2025), -$37.6 million (Q3 2025), and -$31.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | -43.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.07 Mn |
| Sep 30, 2025 | -37.64 Mn |
| Jun 30, 2025 | -31.28 Mn |
| Mar 31, 2025 | -23.25 Mn |
| Dec 31, 2024 | -22.84 Mn |
| Sep 30, 2024 | -68.60 Mn |
| Jun 30, 2024 | -69.95 Mn |
| Mar 31, 2024 | -71.78 Mn |
| Dec 31, 2023 | -38.94 Mn |
| Sep 30, 2023 | -111.20 Mn |
| Jun 30, 2023 | -110.81 Mn |
| Mar 31, 2023 | -72.28 Mn |
| Dec 31, 2022 | -63.80 Mn |
| Sep 30, 2022 | -60.14 Mn |
| Jun 30, 2022 | -93.18 Mn |
| Mar 31, 2022 | -58.70 Mn |
| Dec 31, 2021 | -51.76 Mn |
| Sep 30, 2021 | -119.21 Mn |
| Jun 30, 2021 | -108.97 Mn |
| Mar 31, 2021 | -102.53 Mn |